Creating a new type of vascular access device for dialysis patients
Vertically Integrated Approach to Design a Biologically and Mechanically Optimized Vascular Conduit for Dialysis Vascular Access
This study is working on a new type of blood vessel connector to make it easier and safer for people on dialysis to get the treatment they need, using the latest materials and technology to help reduce problems with current methods.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11176831 on NIH RePORTER |
What this research studies
This research focuses on developing an innovative vascular conduit designed to improve dialysis access for patients. The project aims to create a device that integrates biological and mechanical properties to reduce failure rates associated with current dialysis access methods. By utilizing advanced materials and engineering techniques, the study will prototype and test a new device in animal models before moving towards clinical production. The goal is to enhance the safety and effectiveness of vascular access for hemodialysis patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who are on hemodialysis and require vascular access through arteriovenous fistulae or grafts.
Not a fit: Patients who are not on hemodialysis or those who do not require vascular access for dialysis will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce complications and improve the quality of life for patients requiring dialysis.
How similar studies have performed: Previous research has shown promise in developing biocompatible vascular devices, indicating potential for success with this novel approach.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Roy-Chaudhury, Prabir — Univ of North Carolina Chapel Hill
- Study coordinator: Roy-Chaudhury, Prabir
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.